|
Metropolis Healthcare Limited (METROPOLIS.NS) DCF Valuation
IN | Healthcare | Medical - Diagnostics & Research | NSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Metropolis Healthcare Limited (METROPOLIS.NS) Bundle
No matter if you’re an investor or an analyst, this (METROPOLISNS) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Metropolis Healthcare Limited, you can adjust forecasts and instantly observe the effects.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,558.5 | 9,977.9 | 12,283.2 | 11,482.1 | 12,077.1 | 13,234.9 | 14,503.8 | 15,894.3 | 17,418.2 | 19,088.1 |
| Revenue Growth, % | 0 | 16.58 | 23.1 | -6.52 | 5.18 | 9.59 | 9.59 | 9.59 | 9.59 | 9.59 |
| EBITDA | 2,205.8 | 3,013.6 | 3,813.0 | 3,084.7 | 2,969.9 | 3,665.4 | 4,016.8 | 4,401.9 | 4,823.9 | 5,286.4 |
| EBITDA, % | 25.77 | 30.2 | 31.04 | 26.87 | 24.59 | 27.69 | 27.69 | 27.69 | 27.69 | 27.69 |
| Depreciation | 392.7 | 459.4 | 632.2 | 892.2 | 944.7 | 792.3 | 868.3 | 951.5 | 1,042.7 | 1,142.7 |
| Depreciation, % | 4.59 | 4.6 | 5.15 | 7.77 | 7.82 | 5.99 | 5.99 | 5.99 | 5.99 | 5.99 |
| EBIT | 1,813.1 | 2,554.1 | 3,180.8 | 2,192.5 | 2,025.2 | 2,873.1 | 3,148.6 | 3,450.4 | 3,781.2 | 4,143.7 |
| EBIT, % | 21.18 | 25.6 | 25.9 | 19.1 | 16.77 | 21.71 | 21.71 | 21.71 | 21.71 | 21.71 |
| Total Cash | 2,060.1 | 4,204.3 | 1,806.0 | 1,203.1 | 1,242.9 | 2,691.4 | 2,949.5 | 3,232.3 | 3,542.1 | 3,881.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,282.5 | 1,229.8 | 1,431.4 | 1,268.8 | 1,279.5 | 1,604.3 | 1,758.1 | 1,926.7 | 2,111.4 | 2,313.8 |
| Account Receivables, % | 14.98 | 12.32 | 11.65 | 11.05 | 10.59 | 12.12 | 12.12 | 12.12 | 12.12 | 12.12 |
| Inventories | 244.0 | 405.5 | 511.1 | 445.9 | 386.9 | 480.8 | 526.9 | 577.4 | 632.7 | 693.4 |
| Inventories, % | 2.85 | 4.06 | 4.16 | 3.88 | 3.2 | 3.63 | 3.63 | 3.63 | 3.63 | 3.63 |
| Accounts Payable | 850.3 | 1,105.6 | 901.3 | 940.8 | 994.4 | 1,185.3 | 1,299.0 | 1,423.5 | 1,560.0 | 1,709.6 |
| Accounts Payable, % | 9.94 | 11.08 | 7.34 | 8.19 | 8.23 | 8.96 | 8.96 | 8.96 | 8.96 | 8.96 |
| Capital Expenditure | -362.1 | -282.7 | -306.6 | -526.3 | -637.6 | -514.1 | -563.4 | -617.5 | -676.7 | -741.5 |
| Capital Expenditure, % | -4.23 | -2.83 | -2.5 | -4.58 | -5.28 | -3.88 | -3.88 | -3.88 | -3.88 | -3.88 |
| Tax Rate, % | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 |
| EBITAT | 1,368.2 | 1,914.0 | 2,322.4 | 1,670.8 | 1,481.8 | 2,142.1 | 2,347.5 | 2,572.5 | 2,819.1 | 3,089.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 722.6 | 2,237.2 | 2,136.5 | 2,303.9 | 1,890.7 | 2,192.6 | 2,566.0 | 2,812.0 | 3,081.6 | 3,377.1 |
| WACC, % | 6.21 | 6.21 | 6.21 | 6.22 | 6.21 | 6.21 | 6.21 | 6.21 | 6.21 | 6.21 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 11,606.4 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 3,512 | |||||||||
| Terminal Value | 158,891 | |||||||||
| Present Terminal Value | 117,561 | |||||||||
| Enterprise Value | 129,168 | |||||||||
| Net Debt | 1,344 | |||||||||
| Equity Value | 127,823 | |||||||||
| Diluted Shares Outstanding, MM | 51 | |||||||||
| Equity Value Per Share | 2,487.11 |
What You Will Receive
- Flexible Forecast Inputs: Modify key assumptions (growth %, margins, WACC) effortlessly to explore various scenarios.
- Accurate Market Data: Metropolis Healthcare Limited's financial data pre-loaded to facilitate your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional Design: A sleek Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for assessing projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Offers both unlevered and levered DCF valuation models tailored for Metropolis Healthcare Limited (METROPOLISNS).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet featuring customizable parameters.
- Adjustable Forecast Assumptions: Flexibly update growth rates, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Metropolis Healthcare Limited.
- Visual Dashboard and Charts: Graphical outputs provide a clear summary of essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled data for Metropolis Healthcare Limited (METROPOLISNS) including historical and projected figures.
- Step 3: Modify key assumptions (yellow cells) according to your analysis.
- Step 4: Observe the automatic updates for the intrinsic value of Metropolis Healthcare Limited (METROPOLISNS).
- Step 5: Utilize the generated outputs for your investment strategies or reporting needs.
Why Opt for This Calculator?
- Accurate Data: Utilize authentic Metropolis Healthcare Limited financials for dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations streamline your process, so you don’t have to start from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: An intuitive design and clear, step-by-step guidance ensure ease of use for everyone.
Who Can Benefit from This Product?
- Individual Investors: Make educated decisions about buying or selling Metropolis Healthcare Limited (METROPOLISNS) shares.
- Financial Analysts: Enhance valuation processes with easy-to-implement financial models.
- Consultants: Provide clients with swift and accurate professional valuation insights.
- Business Owners: Gain insights into how major companies like Metropolis Healthcare Limited (METROPOLISNS) are valued to inform your own business strategies.
- Finance Students: Explore valuation methodologies using real-world data and practical scenarios.
What the Template Contains
- Historical Data: Includes Metropolis Healthcare Limited’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Comprehensive templates for calculating the intrinsic value of Metropolis Healthcare Limited.
- WACC Sheet: Pre-structured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust key drivers such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough breakdown of Metropolis Healthcare Limited’s financials.
- Interactive Dashboard: Dynamically visualize valuation results and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.